Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: John M. McCann who wrote (1370)	1/30/1998 11:39:00 PM
From: needawin	Respond to of 2205

Thank you John and Rajendra for the information and advice. I used to own atis a couple of years back . I bought at $6 held for a while and sold later at about $9. When I saw atis finally got Advisory Board approval I knew I should get back in and did but at $15. I should have held long the first time! Now with approval immanient a lot of the risk of holding the stock has been diminished. I'll learn to be more patient. I think they have a remarakable product.

To: John M. McCann who wrote (1370)	1/31/1998 12:57:00 AM
From: Marshall Teitelbaum	Read Replies (1) \| Respond to of 2205

Jack, Thanks for the updates. It will be interesting to see what changes take place among the analysts in the near-term, if any. Webber has consistently been a bull with that 32 target, including through the tough times of Hecht downgrading...different ends of the spectrum. Others potentially interesting to keep an eye on: One of the analysts who had followed ATIS a while back from Principal Financial...I think it is Bill Tanner....has switched employment... I think to Vector. This may mean nothing, but it's something to watch for. Also, there is a Thursday evening discussion through one of the companies, I think Donaldson, Lufkin and Jenrette, highlighting ?21 companies with fda panel prospects. Haven't heard any of the specifics as to how this is being/to be done, but I have been told that one of the ?21 is ATIS. I believe ATIS has already done some type of pilot study a few years back(?94&/or 95) with venous stasis ulcers, but I don't recall any of the specifics. They had said they would be looking at doing at least venous stasis or pressure sores at some point starting this year, but I hadn't heard that they had decided for sure yet as to which. ARe you sure about the venous stasis? For the shorts to relinquish some control, there needs to be either continue gradual following through with meeting expectations, or some things which are ahead of schedule or pleasant surprises along the way. Otherwise, as Harry had said a while back, there are brakes slowing this down. Take care, Marshall